Yuean Global Medical Technology (Tianjin) Co., Ltd.
Leave Your Message
Our flagship clinic syringe pumps are engineered for precise dosing in ICU, anesthesia, oncology, and neonatal care settings worldwide.
A clinic syringe pump is a specialized medical-grade infusion device designed to deliver precise, controlled volumes of fluids, medications, or nutrients directly into a patient's bloodstream or body cavity at programmable flow rates. Unlike conventional gravity-based drip systems, syringe pumps use a motorized mechanism to push the plunger of a syringe at an exact, consistent speed — ensuring unparalleled dosing accuracy.
In clinical environments, even a fractional deviation in drug concentration can have life-altering consequences. Syringe pumps are engineered to eliminate such risks, offering flow rate precision as fine as 0.01 mL/hr, occlusion alarms, air bubble detection, and tamper-resistant locking mechanisms. These capabilities make them indispensable in intensive care units (ICU), operating theaters, neonatal wards, and oncology departments.
Modern clinic syringe pumps integrate seamlessly with hospital information systems (HIS), nurse call systems, and electronic medical records (EMR), enabling real-time monitoring, data logging, and remote adjustment — a cornerstone of today's smart hospital infrastructure.
Clinical studies confirm that intelligent syringe pumps reduce medication errors by up to 73% compared to manual dosing methods, directly improving patient outcomes in critical care settings.
The global syringe pump market was valued at approximately USD 1.2 billion in 2023 and is projected to reach USD 2.1 billion by 2030, growing at a CAGR of over 8.2%. This growth is driven by rising chronic disease prevalence, expanding ICU infrastructure in emerging markets, and the accelerating adoption of smart infusion systems in developed healthcare economies.
Asia-Pacific leads the fastest growth trajectory, with China, India, and Southeast Asian nations investing heavily in hospital modernization programs. North America and Europe remain dominant in terms of technology sophistication, regulatory standards, and per-unit revenue.
Programmable flow rates from 0.01 to 1200 mL/hr with ±2% accuracy, ensuring exact drug delivery even at micro-dose levels for neonatal and critical care patients.
Intelligent occlusion detection, near-end and end-of-dose alerts, air-in-line sensors, and battery low warnings keep clinical staff informed at every stage of infusion.
Wi-Fi and wired network integration enables remote monitoring, drug library updates, and seamless EMR/HIS data synchronization for comprehensive patient management.
Built-in rechargeable battery provides up to 8 hours of uninterrupted operation, ensuring patient safety during power outages or patient transport between departments.
Pre-loaded drug libraries with dose-error-reduction software (DERS) prevent under or overdosing by automatically calculating safe dose ranges based on patient weight and clinical protocol.
Mechanical and software-based anti-free-flow mechanisms prevent accidental bolus delivery when the syringe is removed, a critical safety feature in all clinical environments.
From neonatal intensive care to veterinary surgery, the demand for precise dosing spans a remarkably broad spectrum of clinical and industrial environments.
In intensive care units, patients often require multiple simultaneous drug infusions — vasopressors, sedatives, analgesics, and antibiotics — each at precisely controlled rates. Clinic syringe pumps enable multi-channel therapy with independent rate control, reducing the risk of drug interactions and dosing errors that could prove fatal in hemodynamically unstable patients.
Neonates and premature infants require medication doses measured in micrograms per kilogram per minute. Standard infusion systems lack the precision needed for such micro-dosing. Dedicated neonatal syringe pumps with ultra-low flow rates (as low as 0.01 mL/hr) and minimal dead volume are essential for safe pharmacotherapy in this vulnerable population.
Chemotherapy agents have narrow therapeutic windows — too little is ineffective, too much is toxic. Syringe pumps programmed with body-surface-area-based dosing protocols ensure that each patient receives the exact prescribed cytotoxic dose over the correct time period, minimizing adverse effects and maximizing treatment efficacy.
Total intravenous anesthesia (TIVA) relies entirely on syringe pumps to deliver propofol, remifentanil, and other anesthetic agents at target-controlled infusion (TCI) rates. Anesthesiologists depend on the pump's precision and reliability to maintain the exact depth of anesthesia throughout complex surgical procedures.
The veterinary sector has emerged as a significant growth market for syringe pumps. Animals undergoing surgery, receiving chemotherapy, or requiring critical care demand the same precision dosing standards as human patients. Compact, portable syringe pumps designed for veterinary use are now widely adopted in specialist animal hospitals and research institutions globally.
The shift toward home-based healthcare and palliative care has created demand for portable, easy-to-use syringe pumps that patients or caregivers can operate safely outside of hospital settings. These devices deliver pain management medications, hormones, and nutritional supplements, empowering patients to maintain quality of life at home.
Next-generation syringe pumps are integrating artificial intelligence algorithms that analyze real-time patient vitals — blood pressure, heart rate, SpO₂ — and automatically adjust infusion rates to maintain target physiological parameters. This closed-loop approach represents the future of autonomous, patient-adaptive drug delivery.
Hospital networks are deploying cloud-connected infusion pump management platforms that provide centralized visibility over every pump in the facility — tracking usage, maintenance schedules, drug library versions, and alarm histories — dramatically improving operational efficiency and regulatory compliance.
Modern syringe pumps are being designed to integrate with electronic health records, pharmacy management systems, and nurse call platforms through HL7 FHIR and proprietary APIs, creating a fully connected medication management ecosystem that reduces manual data entry and transcription errors.
Manufacturers are increasingly focused on reducing the environmental footprint of syringe pump systems through energy-efficient motors, recyclable components, and longer device lifecycles. Single-use disposable syringe barrels designed for minimal plastic waste are gaining traction in environmentally conscious healthcare markets.
Tianjin Yue'an Medical Technology Co., Ltd. is a leading high-tech enterprise specializing in the R&D, manufacturing, and global distribution of high-end minimally invasive surgical instruments.
Our core product portfolio includes advanced endoscopes, precision laryngoscopes, intelligent infusion pumps, and professional patient warmers, among other high-quality medical devices.
VIEW MORE
Committed to technological innovation and clinical excellence, we integrate independent research and development, standardized production, and professional sales services. We boast a highly skilled R&D team, state-of-the-art Class 100,000 cleanrooms, and a comprehensive, stringent quality management system, strictly adhering to international medical standards to ensure that every product is safe, effective, stable, and reliable.
By continuously delivering innovative, trustworthy, and customized medical solutions, we establish long-term strategic partnerships with healthcare providers and distributors worldwide, contributing to safer and more efficient minimally invasive surgical care across the globe.
Our vision is to become a premier, trusted global provider of high-quality minimally invasive surgical instruments and advanced medical devices.
We are deeply committed to continuous technological innovation, rigorous quality excellence, and unwavering product reliability, striving to make cutting-edge, accessible medical solutions available to healthcare professionals and patients across every corner of the world.
By fostering long-term strategic cooperation with our global partners, we aim to jointly promote safer, more efficient, and patient-centric healthcare systems, contributing to a healthier, brighter future for all.
Since its founding, Tianjin Yue'an Medical has always upheld the original aspiration of putting safety and quality first, staying deeply focused on the research, development and manufacturing of minimally invasive surgical instruments.
Adhering to rigorous international medical standards and a comprehensive, full-cycle quality control system, we meticulously design, develop and produce each product with the utmost professionalism and responsibility. Every detail is strictly inspected and verified to ensure unparalleled product safety, stability and clinical reliability.
Rooted in professional craftsmanship and business integrity, we are dedicated to building long-term, win-win partnerships with global customers, earning enduring trust as a reliable and respected medical device partner worldwide.
Our products cover 17 provinces and cities in China and are exported to more than 30 countries and regions worldwide, including Southeast Asia, Europe and the Middle East.
Our core product portfolio includes advanced endoscopes, precision laryngoscopes, intelligent infusion pumps, and professional patient warmers, among other high-quality medical devices.
Explore our complete range of precise dosing infusion and syringe pump products designed for every clinical scenario.
